Reproductive endocrinology

Effects of carnitine on glucose and lipid metabolic profiles and fertility outcomes in women with polycystic ovary syndrome: A systematic review and meta‐analysis

Clin Endocrinol (Oxf)Published Systematic review and meta-analysis

Authors' conclusion

With the available literature, carnitine seems to improve ovulation and clinical pregnancy and insulin resistance, BMI in women with PCOS. These effects are warranted to be further validated, due to insufficient statistical power.

Study context

Population
Women with Polycystic ovary syndrome (PCOS) diagnosed by Rotterdam or Androgen Excess Society (AES) criteria
Participants
839 women
Comparison
Carnitine vs placebo
Outcome
Ovulation and pregnancy rates
Methodological detailsPublication bias was absent
  • Publication bias was absent

Pooled result

As reported in the abstract

Carnitine vs PlaceboRelative risk (95% CI)
Ovulation; I2 = 0%
3.42(2.39–4.89)
Pregnancy; I2 = 79%
11.05(1.21–100.58)

Further pooled results

OutcomeMD (kg/m²) (95% CI)
BMI, insulin and HOMA-IR (change from baseline) · after treatmentCarnitinevs PlaceboBMI; I2 = 55.0%−0.93 (−1.15 to −0.70)
OutcomeMD (mIU/L) (95% CI)
BMI, insulin and HOMA-IR (change from baseline) · after treatmentCarnitinevs PlaceboInsulin; I2 = 0%−2.47 (−4.49 to −0.45)
OutcomeMD (95% CI)
BMI, insulin and HOMA-IR (change from baseline) · after treatmentCarnitinevs PlaceboHOMA index; I2 = 0%−0.67 (−1.20 to −0.14)

Body mass index (BMI), insulin and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) (change from baseline) · after treatment

No significant reduction in triglyceride, total cholesterol and LDL-C

Original publication

Effects of carnitine on glucose and lipid metabolic profiles and fertility outcomes in women with polycystic ovary syndrome: A systematic review and meta‐analysis. Clin Endocrinol (Oxf). Published 17 February 2023. doi:10.1111/cen.14885

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.